FeesSafety
Pluang+

Anthropic plans IPO to fund AI-driven bioscience, with potential collaboration from Ginkgo Bioworks.

Market News
19 Nov 2026, 03:56 WIB
The Motley Fool
View Source
Bullish
Anthropic plans IPO to fund AI-driven bioscience, with potential collaboration from Ginkgo Bioworks.

Anthropic is set to go public on November 19, raising tens of billions to invest in AI-powered bioscience research automation, including lab robotics. Ginkgo Bioworks, a leader in automated biotech labs, is already working with Anthropic's rival OpenAI and offers a modular, AI-friendly platform. While Anthropic currently has no public ties to Ginkgo, future collaboration is possible as Anthropic expands its bioscience efforts. Investors should note that Anthropic's IPO is not a direct buy signal for Ginkgo's stock at this time.

Ginkgo Bioworks (DNA) is trading at USD 8.44 as of Nov 19, 2026 09:11 WIB, up 1.44% for the day on Pluang. This price is closer to its 52-week low of USD 5.48 than its high of USD 14.98, indicating room for movement within its range. Despite Anthropic's upcoming IPO, Ginkgo's stock shows strong buying interest with 94% of Pluang orders on the buy side and a typical hold time of 10 days, suggesting active investor engagement separate from the IPO news.

More News (DNA)

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App